NASDAQ · CGEN
Compugen Ltd.
Healthcare · Biotechnology
$2.22
Down-$0.07 (-3.15%)
Updated Oct 7, 2026, 11:57 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 150.12M
- P/E ratio
- -7.75
- Dividend yield
- 0.00%
- 52-week range
- $1.95 – $3.24
- Volume
- 265.38K
- Avg. volume
- 403.79K
Price performance · CGEN
CGEN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
CGEN closed at $2.22 after 21 trading sessions, down 13.28% for the selected period.
- Last close
- $2.22
- Period change
- -13.28%
- Period low
- $2.22
- Period high
- $2.56
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $2.32 | $2.331 | $2.205 | $2.22 | 265.38K |
| Oct 5, 2026 | $2.30 | $2.32 | $2.25 | $2.31 | 198.87K |
| Oct 2, 2026 | $2.34 | $2.38 | $2.305 | $2.31 | 113.99K |
| Oct 1, 2026 | $2.39 | $2.435 | $2.33 | $2.34 | 173.35K |
| Sep 30, 2026 | $2.35 | $2.41 | $2.345 | $2.38 | 118.24K |
| Sep 29, 2026 | $2.32 | $2.35 | $2.30 | $2.35 | 117.18K |
| Sep 28, 2026 | $2.34 | $2.345 | $2.315 | $2.33 | 94.07K |
| Sep 25, 2026 | $2.40 | $2.42 | $2.345 | $2.38 | 77.76K |
| Sep 24, 2026 | $2.34 | $2.375 | $2.325 | $2.37 | 111.36K |
| Sep 23, 2026 | $2.45 | $2.47 | $2.305 | $2.34 | 288.33K |
| Sep 22, 2026 | $2.46 | $2.495 | $2.405 | $2.49 | 230.98K |
| Sep 21, 2026 | $2.45 | $2.495 | $2.42 | $2.435 | 217.39K |
| Sep 18, 2026 | $2.47 | $2.49 | $2.45 | $2.49 | 128K |
| Sep 17, 2026 | $2.42 | $2.47 | $2.42 | $2.46 | 122.76K |
| Sep 16, 2026 | $2.41 | $2.47 | $2.40 | $2.41 | 117.64K |
| Sep 15, 2026 | $2.49 | $2.49 | $2.37 | $2.41 | 330.76K |
| Sep 14, 2026 | $2.42 | $2.54 | $2.42 | $2.48 | 144.47K |
| Sep 11, 2026 | $2.47 | $2.4961 | $2.43 | $2.47 | 162.16K |
| Sep 10, 2026 | $2.48 | $2.51 | $2.44 | $2.46 | 206.98K |
| Sep 9, 2026 | $2.55 | $2.55 | $2.46 | $2.48 | 293.78K |
| Sep 8, 2026 | $2.55 | $2.625 | $2.55 | $2.56 | 192.9K |
Latest CGEN news
The latest Smart Investors Daily articles mentioning CGEN.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

